Aimee Jackson

Active

PRiZM+: A phase II Platform study for Relapsed and Refractory prImary CNS lymphoma with Zanubrutinib

Boucher, B. (Co-Investigator), Jackson, A. (Principal Investigator) & Craddock, C. (Researcher)

1/04/22 → 30/06/26

Project: Research

REFRACT (CR-UK): A Sequential Randomised Phase II Trial in Relapsed Follicular comparing standard Chemotherapy with Novel agents

Jackson, A. (Principal Investigator), Fox, S. (Co-Investigator), Gaskell, C. (Co-Investigator) & McIlroy, G. (Co-Investigator)

Genmab A/S, Cancer Research Uk

1/02/22 → 31/07/32

Project: Research

FEDORA: A phase II study to evaluate the safety, toxicity and tolerability of the combination of fedratinib and ropeginterferon alfa-2b, in patients with myelofibrosis

Fox, S. (Co-Investigator), Craddock, C. (Researcher) & Jackson, A. (Principal Investigator)

AOP Orphan Pharmaceuticals GmbH

31/12/21 → 30/06/26

Project: Research

FEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis

Jackson, A. (Principal Investigator), Fox, S. (Co-Investigator) & Craddock, C. (Researcher)

CELGENE INTERNATIONAL SARL

3/12/21 → 30/06/26

Project: Industry

A randomised phase 2 study of ASTX727 versus best supportive care in MDS/MPN Overlap Syndromes

Fox, S. (Researcher), Boucher, B. (Co-Investigator), Craddock, C. (Co-Investigator) & Jackson, A. (Principal Investigator)

BLOODWISE

1/03/21 → 31/08/25

Project: Research

FaR-RMS - An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma

Bowden, S. (Co-Investigator), Kearns, P. (Co-Investigator), Gatz, S. (Principal Investigator), Pirrie, S. (Researcher), Jackson, A. (Researcher), Liu, W. (Researcher) & Gaunt, P. (Researcher)

BAYER

1/01/21 → 30/06/31

Project: EU

COVID19 BMT: A prospective non interventional study to evaluate the role of immune and inflammatory response in recipients of allogeneic haematopoietic stem cell transplantation (SCT) affected by severe COVID19 infection

Bishop, R. (Principal Investigator), Craddock, C. (Co-Investigator) & Jackson, A. (Co-Investigator)

CELGENE INTERNATIONAL II SARL

1/08/20 → 31/12/25

Project: Industry

PACE: The impact of COVID-19 on patients with AML undergoing chemotherapy: an epidemiological study

Jackson, A. (Co-Investigator), Craddock, C. (Co-Investigator), Loke, J. (Principal Investigator), Boucher, B. (Co-Investigator) & Fox, S. (Co-Investigator)

BLOODWISE, CELGENE INTERNATIONAL II SARL

1/04/20 → 30/06/25

Project: Research

COSI: An international randomised clinical trial of therapeutic interventions with the potential to improve outcome in adults with acute myeloid leukaemia and high risk myelodysplasia undergoing allogeneic stem cell transplantation

Craddock, C. (Principal Investigator) & Jackson, A. (Co-Investigator)

ADIENNE s.r.l, Jazz Pharmaceuticals

1/09/19 → 31/12/26

Project: Industry

STELLAR: A Phase 2, Randomised Study of CHOP-R in Combination with acalabrutinib followed by acalabrutinib maintenance compared to CHOP-R followed by acalabrutinib at disease progression for patients...

Craddock, C. (Principal Investigator), Jackson, A. (Co-Investigator), Boucher, B. (Researcher), Siddique, S. (Co-Investigator) & Wheatley, K. (Co-Investigator)

ACERTA PHARMA B V

7/12/18 → 6/06/26

Project: Research

HR-MB: An international High-Risk Medulloblastoma trial

Lawson, A. (Co-Investigator), Kearns, P. (Co-Investigator), Gates, S. (Principal Investigator), Gaunt, P. (Researcher), Pirrie, S. (Researcher), Billingham, L. (Researcher), Homer, V. (Researcher), Jackson, A. (Researcher) & Slade, D. (Co-Investigator)

Cancer Research Uk, SIOP Europe

1/10/18 → 30/09/29

Project: Research

MITHRIDATE, A Multicenter International sTudy comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

Oppong, R. (Co-Investigator), Gaunt, C. (Co-Investigator), Wheatley, K. (Co-Investigator) & Jackson, A. (Principal Investigator)

NOVARTIS PHARMA A.G., GUYS & ST THOMAS CHARITY

21/09/18 → 20/09/29

Project: Research

AMADEUS - Double-blind,IMPACT phase III,Randomised Study to Compare the Efficacy and Safety to Oral AZA(CC-486)Versus Placebo in Subject with Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance after Allogeneic Haematopoietic

Craddock, C. (Principal Investigator), Siddique, S. (Co-Investigator) & Jackson, A. (Co-Investigator)

CELGENE INTERNATIONAL II SARL

1/04/18 → 31/03/28

Project: Industry

CRUK/17/011 FaR-RMS: A multiarm-multistage study for children and adults with localised and metastatic frontline and relapsed RhabdoMyoSarcoma.

Kearns, P. (Co-Investigator), Gatz, S. (Principal Investigator), Liu, W. (Researcher), Gaunt, P. (Researcher), Jackson, A. (Researcher) & Pirrie, S. (Researcher)

SIOP Europe, Cancer Research Uk

1/02/18 → 31/01/28

Project: Research